Allspring Global Investments Holdings LLC Has $263,000 Holdings in DaVita Inc. $DVA

Allspring Global Investments Holdings LLC decreased its holdings in shares of DaVita Inc. (NYSE:DVA) by 9.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,794 shares of the company’s stock after selling 196 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in DaVita were worth $263,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. National Pension Service raised its stake in DaVita by 74.3% during the first quarter. National Pension Service now owns 197 shares of the company’s stock worth $30,000 after acquiring an additional 84 shares in the last quarter. Y.D. More Investments Ltd acquired a new position in DaVita during the first quarter worth about $35,000. Ameritas Advisory Services LLC acquired a new position in DaVita during the second quarter worth about $47,000. NewEdge Advisors LLC raised its stake in DaVita by 20.8% during the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after acquiring an additional 88 shares in the last quarter. Finally, University of Texas Texas AM Investment Management Co. bought a new stake in shares of DaVita during the first quarter worth about $83,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Stock Performance

DaVita stock opened at $129.27 on Friday. DaVita Inc. has a 52-week low of $122.93 and a 52-week high of $179.60. The stock’s 50 day moving average price is $132.02 and its two-hundred day moving average price is $137.65. The stock has a market capitalization of $9.24 billion, a price-to-earnings ratio of 12.71, a PEG ratio of 0.93 and a beta of 1.13.

DaVita (NYSE:DVA) last issued its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping analysts’ consensus estimates of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The company had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. During the same period in the prior year, the firm earned $2.00 earnings per share. DaVita’s revenue for the quarter was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities research analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on DVA shares. Truist Financial set a $140.00 price target on DaVita in a report on Tuesday, October 14th. Wall Street Zen cut DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of DaVita in a report on Friday. Bank of America reduced their target price on DaVita from $145.00 to $140.00 and set an “underperform” rating on the stock in a report on Wednesday, September 10th. Finally, Barclays reduced their target price on DaVita from $160.00 to $149.00 and set an “equal weight” rating on the stock in a report on Thursday, October 9th. Four analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, DaVita currently has an average rating of “Reduce” and a consensus price target of $153.25.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.